* CAPITALS indicate life-threatening. Underline indicate most frequent.
↑ CNS depression may occur with alcohol ; avoid concurrent use.
Intranasal (Adults and Children ≥ 12 yr): 2 sprays in each nostril twice daily.
Intranasal (Children 6–11 yr): 1 spray in each nostril twice daily.
Availability (generic available)
Nasal spray: 665 mcg/spray in 30.5-g bottle (provides 240 sprays)
Assess for symptoms of seasonal allergic rhinitis (sneezing, runny nose, nasal itching) prior to and during therapy.
Administer 2 sprays per nostril twice daily.
Instruct patient to prime nasal spray by releasing 5 sprays or spraying until a fine mist appears before initial use. If unit has not been used within 7 days, re-prime with 2 sprays. Advise patient to discard nasal device after 240 sprays (30 days) even if bottle is not completely empty; correct amount of medication cannot be assured after 240 sprays.
May cause drowsiness. Advise patient to avoid driving or other activities that require alertness until response to medication is known.
Instruct patient to avoid concurrent use of alcohol or other CNS depressants.
Advise females of reproductive potential to notify health care professional if pregnancy is planned or suspected or if breastfeeding.
Relief of symptoms of seasonal allergic rhinitis (rhinorrhea, sneezing, nasal itching).
olopatadine (nasal) is a sample topic from the Davis's Drug Guide.
Nursing Central is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Complete Product Information.